Reuters logo
BRIEF-China Regenerative Medicine International say Dai Yumin acquired 40 pct stake in All Favour
September 21, 2017 / 11:53 AM / a month ago

BRIEF-China Regenerative Medicine International say Dai Yumin acquired 40 pct stake in All Favour

Sept 21 (Reuters) - China Regenerative Medicine International Ltd

* Voluntary announcement Dai Yumin acquired 40% All Favour and became the sole beneficial owner of All Favour

* Deal at a consideration of approximately HK$340 million Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below